The role of heparins and nano-heparins as therapeutic tool in breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The role of heparins and nano-heparins as therapeutic tool in breast cancer
Authors
Keywords
-
Journal
GLYCOCONJUGATE JOURNAL
Volume 34, Issue 3, Pages 299-307
Publisher
Springer Nature
Online
2016-10-24
DOI
10.1007/s10719-016-9742-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate)
- (2016) Farzana Alam et al. BIOMATERIALS
- Emerging aspects of nanotoxicology in health and disease: From agriculture and food sector to cancer therapeutics
- (2016) Zoi Piperigkou et al. FOOD AND CHEMICAL TOXICOLOGY
- Biochemical and toxicological evaluation of nano-heparins in cell functional properties, proteasome activation and expression of key matrix molecules
- (2016) Zoi Piperigkou et al. TOXICOLOGY LETTERS
- Advanced Nanocarriers Based on Heparin and Its Derivatives for Cancer Management
- (2015) Xiaoye Yang et al. BIOMACROMOLECULES
- LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways
- (2015) Seung Woo Chung et al. BIOMATERIALS
- Syndecan-1 and Syndecan-4 Capture Epidermal Growth Factor Receptor Family Members and the α3β1 Integrin Via Binding Sites in Their Ectodomains
- (2015) Haiyao Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells
- (2015) Panagiotis Bouris et al. MATRIX BIOLOGY
- Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
- (2015) Renato V. Iozzo et al. MATRIX BIOLOGY
- Poly-(lactic-co-glycolic-acid)-based particulate vaccines: Particle uptake by dendritic cells is a key parameter for immune activation
- (2015) A.L. Silva et al. VACCINE
- Sulfated Hexasaccharides Attenuate Metastasis by Inhibition of P-selectin and Heparanase
- (2015) Lubor Borsig et al. NEOPLASIA
- Syndecan-2 regulation of morphology in breast carcinoma cells is dependent on RhoGTPases
- (2014) Hooi Ching Lim et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer
- (2014) Achilleas D. Theocharis et al. FEBS Journal
- Antitumor properties of a new non-anticoagulant heparin analog from the mollusk Nodipecten nodosus: Effect on P-selectin, heparanase, metastasis and cellular recruitment
- (2014) Angélica Maciel Gomes et al. GLYCOBIOLOGY
- Glycosaminoglycans in cancer treatment
- (2014) Mattias Belting THROMBOSIS RESEARCH
- Serglycin: At the Crossroad of Inflammation and Malignancy
- (2014) Angeliki Korpetinou et al. Frontiers in Oncology
- Heparin-functionalized polymeric biomaterials in tissue engineering and drug delivery applications
- (2013) Yingkai Liang et al. Acta Biomaterialia
- Dendronized heparin−doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy
- (2013) Wenchuan She et al. BIOMATERIALS
- Heparan sulfate mediates trastuzumab effect in breast cancer cells
- (2013) Eloah Rabello Suarez et al. BMC CANCER
- Binding and inhibition of drug transport proteins by heparin
- (2013) Yunliang Chen et al. CANCER BIOLOGY & THERAPY
- Heparin–protein interactions: From affinity and kinetics to biological roles. Application to an interaction network regulating angiogenesis
- (2013) Franck Peysselon et al. MATRIX BIOLOGY
- Perturbation of the heparin/heparin-sulfate interactome of human breast cancer cells modulates pro-tumourigenic effects associated with PI3K/Akt and MAPK/ERK signalling
- (2013) Yunliang Chen et al. THROMBOSIS AND HAEMOSTASIS
- Tumor vasculature targeting following co-delivery of heparin-taurocholate conjugate and suberoylanilide hydroxamic acid using cationic nanolipoplex
- (2012) Ji-young Kim et al. BIOMATERIALS
- Heparins modulate the IFN-γ-induced production of chemokines in human breast cancer cells
- (2012) Herbert Fluhr et al. BREAST CANCER RESEARCH AND TREATMENT
- Glycosaminoglycans: key players in cancer cell biology and treatment
- (2012) Nikos Afratis et al. FEBS Journal
- Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Deliveredin VivoInhibit Pulmonary Metastasis of Tumor Cells
- (2012) Shuji Mizumoto et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- NFAT promotes carcinoma invasive migration through glypican-6
- (2011) Gary K. Yiu et al. BIOCHEMICAL JOURNAL
- SST0001, a Chemically Modified Heparin, Inhibits Myeloma Growth and Angiogenesis via Disruption of the Heparanase/Syndecan-1 Axis
- (2011) Joseph P. Ritchie et al. CLINICAL CANCER RESEARCH
- Syndecan-1 and Syndecan-4 Are Independent Indicators in Breast Carcinoma
- (2011) Maria E. Lendorf et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Heparan Sulfate Proteoglycans
- (2011) S. Sarrazin et al. Cold Spring Harbor Perspectives in Biology
- Low molecular weight heparin suppresses tissue factor-mediated cancer cell invasion and migration in vitro
- (2011) CAMILLE ETTELAIE et al. Experimental and Therapeutic Medicine
- Heparan sulfate: biological significance, tools for biochemical analysis and structural characterization
- (2010) Christina J. Malavaki et al. BIOMEDICAL CHROMATOGRAPHY
- Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting
- (2010) Achilleas D. Theocharis et al. FEBS Journal
- Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation
- (2010) D. M. Beauvais et al. JOURNAL OF CELL SCIENCE
- Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
- (2010) Renato V. Iozzo et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Physico-chemical features of engineered nanoparticles relevant to their toxicity
- (2010) Bice Fubini et al. Nanotoxicology
- Glypican-3 reexpression regulates apoptosis in murine adenocarcinoma mammary cells modulating PI3K/Akt and p38MAPK signaling pathways
- (2009) C. Buchanan et al. BREAST CANCER RESEARCH AND TREATMENT
- Unfractionated Heparin and New Heparin Analogues from Ascidians (Chordate-Tunicate) Ameliorate Colitis in Rats
- (2009) Celso L. R. Belmiro et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Heparin-based nanoparticles
- (2009) Melissa M. Kemp et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation
- (2008) Ivan Stigliano et al. BREAST CANCER RESEARCH AND TREATMENT
- Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor
- (2008) Esak Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Biodegradable Polylactic Acid Polymer with Nisin for Use in Antimicrobial Food Packaging
- (2008) T. Jin et al. JOURNAL OF FOOD SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now